LianBio American Depositary Shares
LIAN
LIAN was delisted on the 18th of March, 2024.
38 hedge funds and large institutions have $118M invested in LianBio American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 7 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less funds holding
Funds holding: 39 → 38 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
36% less capital invested
Capital invested by funds: $183M → $118M (-$65.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
2L
22NW LP
Seattle,
Washington
|
+$3.94M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$727K |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$340K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$251K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.69M |
| 2 |
BlackRock
New York
|
-$726K |
| 3 |
AAA
Affinity Asset Advisors
New York
|
-$244K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$212K |
| 5 |
Citigroup
New York
|
-$174K |
LIAN Hedge Fund Activity: Q3 2023 in Review
38 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q3 2023, worth a combined $118M — down 36% from $183M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of LIAN and 6 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 8 added.
The largest buyer was 22NW LP, adding an estimated $3.94M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $9.69M sold.
- 38 institutional investors held LianBio American Depositary Shares (LIAN) as of Q3 2023, down from 39 in Q2 2023.
- Funds reported $118M of LianBio American Depositary Shares stock for Q3 2023, down 36% quarter-over-quarter.
- 6 funds opened new LianBio American Depositary Shares positions in Q3 2023 and 7 closed out, a net change of -1 holder.
- The largest LianBio American Depositary Shares buyer in Q3 2023 was 22NW LP, an estimated $3.94M added.
- The largest LianBio American Depositary Shares seller in Q3 2023 was Cormorant Asset Management, an estimated $9.69M sold.
Based on aggregated 13F filings for Q3 2023.